The U.S. Federal Reserve (Fed) pumped $29.4 billion into the banking system on Friday, sparking optimism on crypto social media. While the move aimed at easing liquidity concerns and is supportive of ...

Weight loss injections have gained popularity as a quick solution for shedding pounds, but are they safe? We’ll explore the safety, benefits and potential risks associated with weight loss injections ...

PD-1 and PD-L1 inhibitors are types of immune checkpoint inhibitors, which are immunotherapy medications for treating cancer. Immunotherapy helps the immune system find and kill cancer cells. Some ...

AbbVie's earnings topped estimates, and it offered an upbeat view of 2025 AbbVie Inc.'s stock rose 7.7% Friday to lead S&P 500 gainers after the drug company beat fourth-quarter earnings estimates and ...

AbbVie Inc (NYSE:ABBV)., a leading biopharmaceutical company with a market capitalization of $311.86 billion, has been at the forefront of the industry with its diverse portfolio of pharmaceuticals ...

After the FDA reaffirmed the end of Zepbound’s two-year shortage, drug companies have announced shortages for 32 presentations of seven medications. Here are seven new shortages, according to drug ...

Introduction of biosimilars for the rheumatology drug adalimumab, whose original branded version Humira has long been a blockbuster, appears to have led to a dramatic drop in net spending for these ...

If you or someone you know has a condition called chronic spontaneous urticaria (CSU), you may have heard about Xolair. In 2014, Xolair became the first medicine to be approved for treating this ...

AbbVie delivered Y/Y growth in the second quarter despite Humira’s decline, with Skyrizi and Rinvoq as key growth drivers, achieving 45% and 56% Y/Y growth, respectively. I expect Skyrizi to become a ...

How Does Evenity Work for Osteoporosis? Throughout our lives, our bodies are constantly forming new bone and breaking down old bone. As we get older, the body begins to break down more bone than it ...